{"id":"W1117787078","doi":"10.1016/j.clml.2015.07.650","title":"Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Centre Hospitalier de l’Université de Montréal; University of Alberta; McGill University; Princess Margaret Cancer Centre; Thunder Bay Regional Health Sciences Centre; McMaster University; Hôpital Maisonneuve-Rosemont; St. Paul's Hospital; Memorial University of Newfoundland; University of British Columbia; Lakehead University; University of Toronto; Western University; University of Windsor; Jewish General Hospital","funders":"World Health Organization","keywords":"Medicine; Polycythemia vera; Phlebotomy; Ruxolitinib; Internal medicine; Oncology; Myelofibrosis; Thrombosis; Disease; Pegylated interferon; Intensive care medicine; Immunology; Bone marrow; Ribavirin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009172705,0.0004736224,0.001001759,0.0001714534,0.0005344886,0.00008130149,0.0003725914,0.0004397728,0.00008958144],"category_scores_gemma":[0.001767054,0.0003205716,0.0007340471,0.0004702055,0.0007156759,0.0001754019,0.0001074172,0.0003333416,0.00005324854],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003395055,"about_ca_system_score_gemma":0.006746494,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.006793501,"about_ca_topic_score_gemma":0.02525415,"domain_scores_codex":[0.9965697,0.0003071326,0.001056057,0.0007881214,0.0005782763,0.0007007135],"domain_scores_gemma":[0.9956995,0.001140621,0.0003769448,0.0008698417,0.0009546019,0.0009585391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002935037,0.002114249,0.6584635,0.0001687192,0.003026251,0.000124453,0.009012142,0.0000802084,0.0006066727,0.1074362,0.02047291,0.1955596],"study_design_scores_gemma":[0.007949897,0.001714613,0.9679914,0.0002410938,0.0005432165,0.000144688,0.00225245,0.001532539,0.001883392,0.002747175,0.01260543,0.00039416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796574,0.003748451,0.000170314,0.006312597,0.001040151,0.003146705,0.0001698816,0.00009573084,0.00565884],"genre_scores_gemma":[0.9927644,0.000181687,0.003063203,0.001565484,0.0006667969,0.0007158438,0.00005948099,0.0000768091,0.0009063215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3095278,"threshold_uncertainty_score":0.9999247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06055785830586164,"score_gpt":0.3405440413676777,"score_spread":0.2799861830618161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}